SBSamia Benzazia

Samia Benzazia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samia Benzazia has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Abdelkader Basli

    Research Laboratory of Interactions, Biodiversity, Ecosystems and Biotechnology, Department of Nature and Life Sciences, Faculty of Sciences University 20 August 1955 Skikda Skikda Algeria

    1 shared publication
  • Ilyas Yildiz

    Tokat Gaziosmanpaşa Üniversitesi

    1 shared publication
  • Ismahan Ounissi

    Research Laboratory of Interactions, Biodiversity, Ecosystems and Biotechnology, Department of Nature and Life Sciences, Faculty of Sciences University 20 August 1955 Skikda Skikda Algeria

    1 shared publication
  • Jihane Bounaas

    Research Laboratory of Interactions, Biodiversity, Ecosystems and Biotechnology, Department of Nature and Life Sciences, Faculty of Sciences University 20 August 1955 Skikda Skikda Algeria

    1 shared publication
  • Ramazan Erenler

    Department of Chemistry, Faculty of Arts and Sciences, Tokat Gaziosmanpasa University, Tokat

    1 shared publication
  • Sarah Rahal

    Faculty of Sciences Department of Biochemistry Laboratory of Microbiology and Molecular Biology (LMMB) Badji‐Mokhtar‐Annaba University Annaba Algeria

    1 shared publication

Latest Publications

  • LC–ESI–MS/MS Profiling and In Vitro Evaluation of Antioxidant, Enzymatic Inhibitory, and Cytotoxic Activities, Along With Complementary In Vitro and In Silico Assessment of the Antibacterial Potential of Centaurea papposa Leaf Extracts

    by Jihane Bounaas, Abdelkader Basli, Ismahan Ounissi, Sarah Rahal, Samia Benzazia, Ramazan Erenler, Ilyas Yıldız, Tevfik Özen, Sarmad Marah

    The main objective of this study was to characterize the phenolic composition of the hydromethanolic extract and its fractions from Centaurea papposa leaves, and to evaluate their antioxidant, enzymatic inhibitory, cytotoxic, and antibacterial activities. In addition, molecular docking analysis was performed using dihydropteroate synthase as the bacterial target enzyme to explore the interactions with major phenolic compounds. LC‐MS/MS analysis identified shikimic acid and chlorogenic acid as predominant in the hydromethanolic extract. In the ethyl acetate fraction, vanillic acid, protocatechuic acid, chlorogenic acid, and shikimic acid were the major constituents. Meanwhile, the chloroform fraction was rich in salicylic acid and luteolin. Furthermore, the antioxidant assays, including 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH), 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid) (ABTS + ), ferric reducing power (FRAP), and phenanthroline, revealed that the ethyl acetate fraction had significant activity, varying between 5.20 and 65.02 µg/mL. With regard to enzyme inhibition, all extracts were found to be ineffective. Based on the cytotoxicity results, the ethyl acetate fraction exhibited significant inhibitory effects against HEp‐2 and HCT‐116, with an IC 50 value below 40 µg/mL. Concerning the antibacterial activity, the chloroform fraction was found to be the most effective against Staphylococcus aureus , Pseudomonas aeruginosa , and Escherichia coli (MIC = 62.5 µg/mL). Whereas the ethyl acetate fraction showed excellent activity against Proteus mirabilis , with an inhibition zone of 22 mm. The results of molecular docking indicated that most of the compounds exhibited good stability within the DHPS active site. Among them, salicylic acid emerged as the most stable compound, demonstrating a remarkable affinity as reflected by its docking score of −6.901 kcal/mol. Overall, this plant could have therapeutic potential against oxidative stress, bacterial infections, and cancer.